CTNNB1 and breast carcinoma: Effects on beta-catenin in vitro and in vivo, were severely impaired in primary breast cancer cells and in MCF7met cells treated with c-Met kinase inhibitor (Figure 6E and Figure 7E) as well as in xenografts origining from MDA-MB-231shMet (Figure 7D).